Single Technologies
Founded Year
2012Stage
Series A | AliveTotal Raised
$8.56MLast Raised
$6.1M | 3 yrs agoAbout Single Technologies
Single Technologies develops a new type of single molecule sensitive 3D imaging system to improve research, drug discovery and diagnostics. The technology is a breakthrough approach to screen biomolecules or compounds in live single cells with high throughput.
Loading...
Loading...
Single Technologies Patents
Single Technologies has filed 2 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
8/27/2015 | 2/2/2021 | Microscopy, Spectroscopy, Microscopes, Cell imaging, Molecular biology | Grant |
Application Date | 8/27/2015 |
|---|---|
Grant Date | 2/2/2021 |
Title | |
Related Topics | Microscopy, Spectroscopy, Microscopes, Cell imaging, Molecular biology |
Status | Grant |
Latest Single Technologies News
Dec 3, 2020
NEW YORK — Single Technologies said on Thursday that it has raised €5 million ($6.1 million) through an oversubscribed share offering, which it will use to accelerate development of its 3D sequencing platform. The financing included existing investors, as well as new investors Jens von Bahr, Rothesay, Cygnus Montanus Trust, Ulf Landegren, and Andreas Ehn. To read the full story.... Email:
Single Technologies Frequently Asked Questions (FAQ)
When was Single Technologies founded?
Single Technologies was founded in 2012.
Where is Single Technologies's headquarters?
Single Technologies's headquarters is located at Sankt Eriksgatan 48F, Stockholm.
What is Single Technologies's latest funding round?
Single Technologies's latest funding round is Series A.
How much did Single Technologies raise?
Single Technologies raised a total of $8.56M.
Who are the investors of Single Technologies?
Investors of Single Technologies include Andreas Ehn, Rothesay Life, Jens von Bahr, Ulf Landegren, Cygnus Montanus Stiftelse and 5 more.
Loading...
Loading...